Hyperbaric Oxygen Therapy (HBOT): Evidence, Uses, Risks & What to Expect (2025 Guide)

Summary: Hyperbaric oxygen therapy (HBOT) delivers 100% oxygen inside a pressurized chamber (typically ~1.9–3.0 ATA) to drive more oxygen into blood plasma and hypoxic tissues. In the U.S., HBOT is FDA‑cleared for a defined set of conditions (e.g., decompression illness, carbon monoxide poisoning, radiation injury, compromised grafts/flaps, select infections, sudden hearing/vision emergencies, and certain non‑healing diabetic foot ulcers). Uses like chronic stroke recovery or long COVID remain investigational. Choose a UHMS‑accredited facility and discuss goals, evidence, and risks with a qualified clinician.

What Is HBOT?

Hyperbaric oxygen therapy (HBOT) is a medical treatment in which you breathe 100% oxygen while inside a sealed chamber pressurized above normal atmospheric pressure. The increased pressure helps dissolve additional oxygen directly into plasma, delivering oxygen deeper into tissues—even where blood flow is reduced.

How HBOT Works

Physics advantage: Higher ambient pressure + pure oxygen = more oxygen dissolved in plasma beyond hemoglobin’s capacity, improving delivery to oxygen‑starved tissue.
Repair biology: Elevated tissue oxygen can support angiogenesis (new blood vessel growth), fibroblast/collagen activity for wound closure, and help immune cells control specific infections.
Typical parameters: Treatments commonly use ~1.9–3.0 atmospheres absolute (ATA) for about 90–120 minutes per session, per indication‑based protocols.

FDA‑Cleared Medical Uses

In the U.S., HBOT devices are cleared for specific conditions. Commonly treated, guideline‑supported indications include:

Diving & procedural gas disorders: Decompression sickness, air/gas embolism.
Toxic exposures: Carbon monoxide poisoning (including pregnancy) and cyanide poisoning (often in smoke inhalation).
Radiation injuries: Osteoradionecrosis and soft‑tissue radionecrosis as adjuncts to conventional care.
Wounds & grafts/flaps: Preparation/preservation of compromised skin grafts or flaps; select diabetic foot ulcers (see Medicare criteria below).
Severe infections & trauma: Clostridial myonecrosis (gas gangrene), chronic refractory osteomyelitis, crush injury/acute traumatic ischemia, necrotizing soft‑tissue infections (as part of a surgical/antimicrobial plan).
Sensory emergencies: Sudden sensorineural hearing loss and central retinal artery occlusion (time‑sensitive).
Severe anemia (specific scenarios): When transfusion is not possible or available.

Note: Professional groups (e.g., UHMS) periodically update guidance; facilities should follow current standards and safety codes.

What to Expect in a Treatment Course

Where: Hospital‑based units or UHMS‑accredited outpatient centers; chambers may be monoplace (one person) or multiplace.
During pressurization: You’ll feel ear pressure (like airplane descent). Staff teach equalization techniques and monitor throughout.
Session length & number: ~90–120 minutes. Emergencies may need a handful of treatments; chronic problems often require 20–30+ sessions.
Monitoring: Vital signs, glucose checks (if diabetic), and indication‑specific assessments are routine.

Safety, Side Effects & Contraindications

Common and usually mild: Ear or sinus barotrauma (pressure/pain), transient nearsightedness after many sessions, fatigue, or claustrophobia.
Uncommon but serious: Oxygen‑toxicity seizures (rare), pulmonary barotrauma, fire risk in oxygen‑rich environments (managed by strict protocols and no prohibited items in the chamber).
Absolute contraindication: Untreated pneumothorax. Many other issues are relative and require case‑by‑case evaluation (e.g., severe COPD with bullae, certain ear/eye conditions, specific medications).

Important: “Mild” or portable zippered bags marketed direct‑to‑consumer are not the same as medical‑grade HBOT. The FDA advises seeking care at inspected, UHMS‑accredited facilities for approved uses.

Access & Coverage

Medicare (U.S.): Covers HBOT for defined indications. For diabetic foot ulcers, criteria include: type 1 or 2 diabetes, Wagner grade III or higher, and failure of at least 30 consecutive days of standard wound care; progress is reassessed every 30 days.
Private insurance: Often mirrors Medicare for cleared indications; off‑label uses typically require prior authorization or are self‑pay.
Costs: Vary by region, setting (hospital vs. outpatient), and indication. Ask for a written plan outlining session count and re‑evaluation points.

Emerging & Investigational Areas

Chronic stroke recovery (neuroplasticity): A randomized controlled trial in chronic post‑stroke patients (6–36 months after stroke) reported improvements in neurological function and brain perfusion imaging after a 40‑session protocol at ~2.0 ATA. Larger multi‑center studies are needed before routine use.

Long COVID: Evidence is mixed. A double‑blind, sham‑controlled RCT using ~40 sessions reported improvements in cognition and quality‑of‑life domains; a separate phase‑II RCT with only 10 sessions did not show clear superiority over sham. HBOT is not FDA‑cleared for COVID‑19 or long COVID.

Sports medicine, TBI, mental health, and others: Research is ongoing; discuss goals, alternatives, and opportunity cost with a hyperbaric specialist before paying out‑of‑pocket.

How to Choose a Safe, Legitimate HBOT Center

Accreditation: Listed by the Undersea & Hyperbaric Medical Society (UHMS).
Clinical governance: Physician‑led program, indication‑based protocols, glucose checks for diabetics, ear‑clearing coaching, and documented emergency procedures.
Informed consent: Clear whether your use is FDA‑cleared vs. off‑label, with realistic expectations and re‑evaluation milestones.

HBOT FAQs

Is HBOT the same as the “mild” chambers advertised online?

No. Medical‑grade HBOT uses rigid chambers, high oxygen, and specific pressures (often ~1.9–3.0 ATA) under medical supervision. Many portable bags are not cleared for oxygen use and are intended for other purposes; misuse can be dangerous.

How many sessions will I need?

Emergencies (e.g., CO poisoning) may require a few treatments; chronic conditions often need 20–30+ sessions. Your plan depends on the indication and your response at periodic reassessments.

Who should avoid HBOT?

People with untreated pneumothorax must not undergo HBOT. Others may need individualized risk assessment (certain lung diseases, ear/sinus issues, and specific medications). A hyperbaric physician will screen you before treatment.

Does HBOT help long COVID?

Results are mixed. One sham‑controlled RCT with approximately 40 sessions showed cognitive and quality‑of‑life improvements, while a 10‑session phase‑II RCT did not demonstrate clear benefit. It’s not FDA‑cleared for this use.

References & Resources

Book Now

Hyperbaric Oxygen Therapy